177 related articles for article (PubMed ID: 38158651)
1. Perioperative Plasma Exchange and Intravenous Immunoglobulin Use for Refractory Heparin-Induced Thrombocytopenia in a Liver Transplant Recipient.
Habibi S; Hsieh TC; Khanna S
Am J Case Rep; 2023 Dec; 24():e941865. PubMed ID: 38158651
[TBL] [Abstract][Full Text] [Related]
2. IVIg for Treatment of Severe Refractory Heparin-Induced Thrombocytopenia.
Padmanabhan A; Jones CG; Pechauer SM; Curtis BR; Bougie DW; Irani MS; Bryant BJ; Alperin JB; Deloughery TG; Mulvey KP; Dhakal B; Wen R; Wang D; Aster RH
Chest; 2017 Sep; 152(3):478-485. PubMed ID: 28427966
[TBL] [Abstract][Full Text] [Related]
3. High-dose intravenous immunoglobulin to treat spontaneous heparin-induced thrombocytopenia syndrome.
Mohanty E; Nazir S; Sheppard JI; Forman DA; Warkentin TE
J Thromb Haemost; 2019 May; 17(5):841-844. PubMed ID: 30773806
[TBL] [Abstract][Full Text] [Related]
4. Pre-operative therapeutic plasma Exchange and intravenous immune globulin for the treatment of heparin induced thrombocytopenia in a lung transplant recipient.
Mandernach MW; Nandavaram S; Salame B; Machuca T; Pelaez A
Transfus Apher Sci; 2019 Aug; 58(4):505-507. PubMed ID: 31387833
[TBL] [Abstract][Full Text] [Related]
5. The Triple HIT: Perioperative Management of Heparin-Induced Thrombocytopenia Using Plasma Exchange, Intravenous Immunoglobulin, and Protamine Infusion for Left Ventricular Assist Device Implantation.
Liu VC; Klompas AM; Stulak JM; Yalamuri SM
J Cardiothorac Vasc Anesth; 2022 Jun; 36(6):1715-1719. PubMed ID: 33933367
[TBL] [Abstract][Full Text] [Related]
6. Intravenous immunoglobulin as an adjunct therapy in persisting heparin-induced thrombocytopenia.
Park BD; Kumar M; Nagalla S; De Simone N; Aster RH; Padmanabhan A; Sarode R; Rambally S
Transfus Apher Sci; 2018 Aug; 57(4):561-565. PubMed ID: 30244713
[TBL] [Abstract][Full Text] [Related]
7. High-dose intravenous immunoglobulin for the treatment and prevention of heparin-induced thrombocytopenia: a review.
Warkentin TE
Expert Rev Hematol; 2019 Aug; 12(8):685-698. PubMed ID: 31274032
[No Abstract] [Full Text] [Related]
8. Therapeutic plasma exchange and intravenous immune globulin in the treatment of heparin-induced thrombocytopenia: A systematic review.
Onuoha C; Barton KD; Wong ECC; Raval JS; Rollins-Raval MA; Ipe TS; Kiss JE; Boral LI; Adamksi J; Zantek ND; Onwuemene OA
Transfusion; 2020 Nov; 60(11):2714-2736. PubMed ID: 32812222
[TBL] [Abstract][Full Text] [Related]
9. Early high-dose intravenous immunoglobulin for refractory heparin-induced thrombocytopenia with stroke: Two case reports.
Makita N; Ohara T; Tsuji Y; Ueda T; Nakamura T; Mizuno T; Makino M
J Stroke Cerebrovasc Dis; 2023 Apr; 32(4):107032. PubMed ID: 36701852
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of intravenous immunoglobulin use in heparin-induced thrombocytopenia.
Aryal MR; Gosain R; Donato A; Katel A; Chakradhar R; Dhital R; Kouides PA
Blood Coagul Fibrinolysis; 2020 Jul; 31(5):287-292. PubMed ID: 32398463
[TBL] [Abstract][Full Text] [Related]
11. Successful preemptive renal retransplantation in a patient with previous acute graft loss secondary to HIT type II: a case report and review of literature.
Muzaffar M; Li X; Ratnam S
Int Urol Nephrol; 2012 Jun; 44(3):991-4. PubMed ID: 21424572
[TBL] [Abstract][Full Text] [Related]
12. Rapid and durable response to intravenous immunoglobulin in delayed heparin-induced thrombocytopenia: a case report.
Lei BZ; Shatzel JJ; Sendowski M
Transfusion; 2017 Apr; 57(4):919-923. PubMed ID: 27943368
[TBL] [Abstract][Full Text] [Related]
13. Novel Use of Cangrelor With Heparin During Cardiopulmonary Bypass in Patients With Heparin-Induced Thrombocytopenia Who Require Cardiovascular Surgery: A Case Series.
Gernhofer YK; Banks DA; Golts E; Pretorius V
Semin Thorac Cardiovasc Surg; 2020 Winter; 32(4):763-769. PubMed ID: 31610233
[TBL] [Abstract][Full Text] [Related]
14. Heparin-induced thrombocytopenia from venous thromboembolism treatment.
Begelman SM; Hursting MJ; Aghababian RV; McCollum D
J Intern Med; 2005 Dec; 258(6):563-72. PubMed ID: 16313480
[TBL] [Abstract][Full Text] [Related]
15. Argatroban for heparin-induced thrombocytopenia in hepato-renal failure and CVVHD.
Dager WE; White RH
Ann Pharmacother; 2003 Sep; 37(9):1232-6. PubMed ID: 12921505
[TBL] [Abstract][Full Text] [Related]
16. A population-based analysis on the use of therapeutic plasma exchange and intravenous immunoglobulin in heparin-induced thrombocytopenia.
Soares Ferreira Júnior A; Boyle SH; Kuchibhatla M; Onwuemene OA
Thromb Res; 2021 May; 201():6-14. PubMed ID: 33621860
[TBL] [Abstract][Full Text] [Related]
17. Refractory Heparin-Induced Thrombocytopenia With Cerebral Venous Sinus Thrombosis Treated With IVIg, Steroids, and a Combination of Anticoagulants: A Case Report.
Gonzales M; Pipalia A; Weil A
J Investig Med High Impact Case Rep; 2019; 7():2324709619832324. PubMed ID: 30939936
[TBL] [Abstract][Full Text] [Related]
18. Intravenous Immune Globulin (IVIG) for Treatment of Autoimmune Heparin-Induced Thrombocytopenia: A Systematic Review.
Dougherty JA; Yarsley RL
Ann Pharmacother; 2021 Feb; 55(2):198-215. PubMed ID: 32693627
[TBL] [Abstract][Full Text] [Related]
19. A Case of Argatroban Refractory Heparin Induced Thrombocytopenia and Thrombosis.
Seiler JA; Durrani AK; Ahmeti M
Am Surg; 2023 Aug; 89(8):3574-3575. PubMed ID: 36919894
[TBL] [Abstract][Full Text] [Related]
20. Effect of renal function on argatroban therapy in heparin-induced thrombocytopenia.
Guzzi LM; McCollum DA; Hursting MJ
J Thromb Thrombolysis; 2006 Dec; 22(3):169-76. PubMed ID: 17103051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]